Professional virtual currency information station welcome
We have been making efforts.

24-hour news update Page 66

24-hour cryptocurrency news update

India’s Energy Crisis Seeks Imports, And Argentina’s LPG Becomes A New Supply Source And Export Driver

According to Russian media reports on March 12, India is facing a severe energy crisis and has begun importing liquefied petroleum gas (LPG) from Argentina to ensure domestic supply. According to a report by The Nation on Thursday, the country, which will become the world's most populous country from 2023, has only enough liquefied petroleum gas reserves to last ten days, prompting the Modi government to urgently find suppliers in different markets around the world.

_Argentina oil distribution map_Argentina oil resources

Liquefied petroleum gas (mainly used for cooking and heating) is a key energy source in India. According to data cited by the professional media "Argus", the country's state-owned enterprises are purchasing at a price of US$350 to US$400 per ton higher than the reference price to ensure stable supply.

India consumes about 2 million tons of LPG every month. For comparison, Argentina's annual consumption is about 1.5 million tons. In a densely populated country with a limited gas pipeline network, liquefied gas tanks remain the main source of energy for millions of homes and businesses. Last year, the country imported nearly 21 million tons of liquefied petroleum gas through the Strait of Hormuz, one of the world's most important energy trade routes that was blocked after the United States and Israel launched attacks on Iran.

Market interest in Argentine natural gas is heating up. This world-class unconventional oil and gas reserve area in the Patagonia region has become a core driving force for the South American country's energy development and opened up channels for new natural gas exports, including associated gas.

(Original title: India recurres an este país latinoamericano para abastecerse de gas ante la emergencia energética)

CBA Regular Season Beijing Enterprises Faced Tianjin At Home, Beijing Enterprises Beat Tianjin 106-98

Live Broadcast News March 13th CBA regular season, Beijing Enterprises vs. Tianjin at home. Beijing Enterprises currently ranks 13th with 11 wins and 13 losses after two consecutive losses, while Tianjin ranks 16th with 9 wins and 15 losses after two consecutive wins.

At the beginning of the game, both sides quickly entered the state. Beijing Control counterattacked continuously, leading to double digits with a wave of 13-3 attacks. Everyone in Tianjin was chasing points. In the first quarter, North Control led by 9 points. In the second quarter, the two sides started a tug-of-war. Riller and Liao Sanning fired from the outside to open up the score. Lin Tingqian responded strongly with two consecutive three-pointers from the outside. At the half, North Control still led by 8 points. In the second half, the two sides continued to go back and forth around the 10-point difference. Liao Sanning and Zou Yuchen scored consecutive points inside and outside, and Tianjin was able to respond and get within 6 points. In the final quarter, Beijing Control still held a lead of more than two goals. Shen Zijie made contributions in offense and defense, and Zou Yuchen made consecutive tip-ins to kill the game. In the end, Beijing Control defeated Tianjin 106-98.

Data from both parties

Beijing Enterprises (12-13): Liao Sanning 23 points, 7 rebounds, 3 assists and 3 steals, Riller 23 points, 6 rebounds, 7 assists and 2 steals, Zou Yuchen 20 points, 7 rebounds, 1 assist and 2 steals, Zhu Songwei 16 points, 2 rebounds, 2 assists and 2 steals, House 8 points, 3 rebounds and 9 assists, Perry 7 points, 6 rebounds and 2 assists, Shen Zijie 7 points, 5 rebounds and 3 assists, Du Bochao 2 points

Tianjin (9-16): Lin Tingqian 21 points, 2 rebounds, 5 assists and 4 steals, Hamlet 18 points, 1 rebound and 9 assists, Zheng Haoran 15 points, 3 rebounds and 1 assist, Lai Junhao 15 points, 2 rebounds and 1 assist, David James 10 points, 11 rebounds and 3 assists, Tanizawa Yu 9 points, 4 rebounds and 5 assists, Reynolds 7 points, 12 rebounds, 1 assist and 3 blocks, Tian Yu 3 points, 1 rebound and 1 assist

Click to enter the topic:

2025-2026 CBA League Season

Professor Ren Zuyuan, A Famous Neurosurgery Expert, Passed Away And A Funeral Was Held On March 18.

_Pioneering neurosurgeons_Pyongyang neurosurgeons

obituary

Professor Ren Zuyuan, a member of the Communist Party of China, a famous neurosurgery expert, the former director of the Department of Surgery and the former director of the Department of Neurosurgery of Peking Union Medical College Hospital, passed away due to illness on March 12, 2026 at the age of 91.

It is scheduled to be held at 7:30 a.m. on March 18, 2026 (Wednesday) in the farewell hall on the ground floor of the Surgery Building of Peking Union Medical College Hospital.

This is your obituary.

Peking Union Medical College Hospital

March 13, 2026

Contact number:

13466630378 (Teacher Lu)

17701220936 (Teacher Guo)

13520190154 (Teacher Zhang)

69156808 (Retired Cadres Department)

69156809(fax)

Life of Professor Ren Zuyuan

Ren Zuyuan, male, from Dongyang City, Zhejiang Province, was born on September 11, 1934. He graduated from the Medical Department of Shanghai Second Medical College (now Shanghai Jiao Tong University School of Medicine) in July 1959, and was assigned to work at Peking Union Medical College Hospital in the same year. He has successively served as the attending physician, deputy chief physician, chief physician, professor, and doctoral supervisor of neurosurgery. From 1987 to 2000, he served as the director of the Neurosurgery Department of Peking Union Medical College Hospital, and from 1991 to 2000, he served as the director of the Department of Surgery. He has enjoyed special government subsidies from the State Council since 1992. He received the "Outstanding Contribution Award" from Peking Union Medical College Hospital in 2011, the "Lifetime Achievement Award" from the Neurosurgery Branch of the Chinese Medical Association in 2019, and the "Lifetime Achievement Award" from the Chinese Pituitary Adenoma Collaborative Group in 2024.

P.C. neurologists_Pyongyang neurosurgeons_

Ren Zuyuan in his youth

Professor Ren Zuyuan served as a standing committee member of the Third Committee of the Neurosurgery Branch of the Chinese Medical Association, a deputy director of the Neurosurgery Society of the Beijing Branch of the Chinese Medical Association, a member of the Academic Committee of the Chinese Academy of Medical Sciences and Peking Union Medical College, a standing member of the Academic Committee of Peking Union Medical College Hospital, and a member of the Beijing Cerebrovascular Disease Prevention and Treatment Steering Group. He has served as a review member of the National Science and Technology Awards, a review expert of the National Natural Science Foundation, the former Science Fund of the Ministry of Health, the China Health Science and Technology Achievements Appraisal Committee, and the Medical Device Committee of the State Medical Administration. He serves as a standing editorial board member of the "Chinese Journal of Neurosurgery", an academic consultant of "Chinese Journal of Modern Surgery", "Chinese Journal of Neurosurgical Disease Research", and an editorial board member of more than ten professional academic journals such as "World Medical Journal", "Modern Neurological Diseases Journal", "Chinese Journal of Otolaryngology and Skull Base Surgery", "Chinese Journal of Minimally Invasive Neurosurgery", "Chinese Journal of Clinical Neurosurgery", etc.

Professor Ren Zuyuan has been deeply involved in the field of neurosurgery for more than 60 years, and has reached internationally advanced levels in the field of surgical treatment of deep brain tumors, various types of intracranial aneurysms, arteriovenous malformations, brainstem tumors, ischemic cerebrovascular disease, functional neurosurgery and spinal cord tumors. He created or improved more than ten neurosurgical procedures and optimized and developed a variety of surgical instruments. Some of his designs are still important prototypes of modern neurosurgical instruments. He pioneered transsphenoidal microsurgery in the treatment of pituitary adenomas in China and has completed more than 4,000 surgeries. By continuously improving surgical methods and overcoming a number of key technical problems, the indications for surgery have been significantly expanded and the treatment effect has been improved. He was the first in China to propose the concept of "invasive pituitary adenoma" and conduct systematic research, establishing a comprehensive treatment strategy that combines surgery, drugs and radiotherapy. Collaborating with the pathology team, he was the first in China to publish a new classification of pituitary adenomas and put forward important academic arguments for ACTH cell proliferation.

P.C. neurologists_Pyongyang neurosurgeons_

Ren Zuyuan works in the office

As one of the main advocates of the multidisciplinary collaborative diagnosis and treatment model of pituitary adenomas, Professor Ren Zuyuan has been vigorously promoting the construction of a multidisciplinary collaborative diagnosis and treatment team for pituitary adenomas since the 1980s, together with academician Shi Yifan of the Department of Endocrinology, Professor Wang Weijun, Professor Yin Zhaoyan, and Professor Su Changbao of the Department of Neurosurgery, pioneering the comprehensive diagnosis and treatment of pituitary adenomas in China.

Professor Ren Zuyuan has chaired or participated in important research projects such as the National “Eighth Five-Year Plan”, “Ninth Five-Year Plan” and “Tenth Five-Year Plan”, the National Natural Science Foundation, the Ministry of Education’s Doctoral Program and Postdoctoral Fund, etc. He has published more than 100 academic papers, and participated in the compilation of monographs such as "Surgery", "Neurosurgery", "Diagnosis and Treatment of Pituitary Tumors", "Pioneering Endocrinology and Metabolism", "Pioneering Medical Dictionary", "Endocrine Gland Surgery", etc.

Professor Ren Zuyuan went to Australia for further study for one and a half years. After that, he went to the United States, the United Kingdom, France, Germany, the Netherlands, Canada, Japan, Belgium and other countries as well as Hong Kong and Taiwan for academic exchanges and lectures, and was employed as a visiting professor. He actively received visits from foreign experts, carried out academic exchanges and surgical demonstrations, and made important contributions to promoting exchanges and cooperation in the field of neurosurgery at home and abroad.

Professor Ren Zuyuan has won a number of important scientific and technological achievement awards. "Transsphenoidal Resection of Micro Tumors in the Pituitary Area" won the second prize of the Science and Technology Progress Award of the Ministry of Health in 1981, and "Clinical and Basic Research on Hormone-Secreting Pituitary Tumors" won the Science and Technology Progress Award of the Ministry of Health in 1991. The first prize for progress, the first prize for the National Science and Technology Progress Award in 1992 (the second completer), and the national "Eighth Five-Year Plan" research project "CT-guided stereotaxic intracerebral hematoma evacuation experiment and clinical research on hypertensive cerebral hemorrhage" won the third prize of the National Science and Technology Commission in 1997. In addition, he has won 14 medical research achievement awards from Peking Union Medical College Hospital and been named an advanced worker of the hospital five times.

In 1991, neurosurgeons took a group photo to celebrate the 70th anniversary of the founding of Peking Union Medical College Hospital. Professor Ren Zuyuan was second from left in the front row.

Professor Ren Zuyuan has devoted his life to clinical practice and has won wide respect from all walks of life with his noble medical ethics and superb medical skills. He was erudite and elegant, rigorous in his studies, generous in his conduct, and taught by words and deeds. He was a good teacher and helpful friend in the eyes of future generations. He attaches great importance to medical talent training and technology promotion, and has visited hospitals in more than 20 provinces and cities across the country to provide lectures, difficult case consultations and surgical demonstrations to help improve the level of grassroots neurosurgery. He continues to explore, achieve great results, and win many awards, and his fruitful results have pushed China's neurosurgery to the forefront of the world. He has devoted himself to teaching undergraduates, graduate students and advanced researchers, and has trained dozens of master's students, doctoral students and post-doctoral students, cultivating a large number of neurosurgery professionals for the country. Today, these disciples have become the backbone of major neurosurgery centers across the country, inheriting Professor Ren’s original intention as a doctor and scholarly spirit.

The gentleman has passed away, but his style lives on. His benevolence and perseverance, his wisdom and character are like a beacon illuminating the path forward for future generations. His spirit will forever be engraved on the monument of the development of neurosurgery in China, inspiring generations of latecomers to move forward with their ambitions.

Deeply remembering Professor Ren Zuyuan!

Professor Ren Zuyuan is immortal!

Lifetime Car Warranty Promises Are Tempting But Difficult To Fulfill, And There Are Various Reasons For Rejecting The Warranty.

_Lifetime warranty routines of car companies_Lifetime warranty vehicles

Reporter Zhou Ju

"I bought your car because of the lifetime warranty." For bulk consumer goods such as cars, this sentence is the common sentiment of many car consumers.

In recent years, in order to increase market appeal, the commitment to lifetime warranty has been extended from the old joint ventures of fuel vehicles to many independent brands and new energy vehicle companies such as Chery, Xpeng, Lynk & Co, and BYD. For car companies, lifetime warranty is like a reassurance in the fierce competition. It has won a lot of favor from consumers and has become one of their sharp weapons in competing for the market.

However, when there is a real problem with the vehicle and the owner walks into the 4S store with high hopes, he is often greeted with a basin of cold water.

On the third-party complaint platform, there are many complaints about the failure to honor the lifetime car warranty. The reasons for rejection are varied: it may be because a maintenance is overdue, it may be because of a "timing belt not replaced" that has no causal relationship with the fault, it may also be because of a form that was never told to be filled out, or even just because the 4S store where the car was originally sold has closed down – the promise of a lifetime warranty is like a piece of waste paper, easily torn up.

Reasons for rejection of insurance abound

By sorting out the complaint cases, the reasons why car owners are denied lifetime warranty by car companies can be summarized as follows.

One is to forcibly bind the lifetime warranty with maintenance services, which is currently the most common reason for rejection of warranty. Car companies require car owners to have their cars maintained at designated 4S stores and within specified mileage. Once violated, the lifetime warranty rights will be invalidated. "My car suffered two serious gearbox failures. The gearbox assembly was replaced for the first time. However, two years later, dangerous faults such as locking in D5 and no forward power after reversing occurred again. I went to a 4S shop for repairs, but they said that I did not perform maintenance at their shop as required and said that the lifetime warranty clause could not be used and they would not provide free repairs." Mr. Li, the owner of a domestic B-brand car, said.

Mr. Wang, the owner of an L brand car, was busy at work and exceeded the specified mileage during a maintenance. Although the 4S store maintenance record of the entire six years and 110,000 kilometers was perfect, he was told that the lifetime warranty rights were permanently invalidated just because of this "overdue period". In addition, some car owners failed to replace the timing belt as recommended by the after-sales staff of the 4S store, and their turn signal repair requests the following year were rejected on the grounds that they were "out of warranty."

According to Article 32 of the "Regulations on Responsibility for Repair, Replacement and Return of Household Automobile Products", the premise for operators to be exempt from liability is damage caused by consumers "failure to use, maintain, and maintain in accordance with the instructions for use." However, the above-mentioned car owners said that neither the oil maintenance nor the timing belt had any causal relationship with the failure – this was an exemption from their own responsibilities under unreasonable conditions and was suspected of infringing on consumer rights.

Another way to deny coverage is to tie the lifetime warranty to the insurance business. Some car owners complained that when their vehicles had quality problems and needed repairs, dealers refused on the grounds that "car damage insurance was not purchased at the 4S store." This kind of forced bundling of insurance using warranty as a bargaining chip is suspected of violating the provisions of the Consumer Rights Protection Law prohibiting the setting of unreasonable conditions and increasing consumer responsibilities.

What's more, the scope of the lifetime warranty is vague at the time of sales, and when problems arise with parts, they begin to unilaterally limit the scope of the "lifetime warranty".

A car owner of a new energy B brand said that when purchasing the car, the manufacturer clearly promised a "lifetime warranty on the battery cells." However, when the fault of the collection cable in the battery pack caused the vehicle's EV to be limited, the manufacturer argued that "the collection cable does not belong to the battery cell" and refused to repair it free of charge. The car owner asked in confusion: "Without the collection cable, how can the battery cells be monitored? How do they work? This is clearly the 'nervous system' of the battery cells!"

Similar situations are common: the vehicle seat slide is damaged, and the manufacturer says "it is an accessory and not covered by the vehicle warranty"; the driving recorder is damaged, and the 4S store says "the recorder is not covered by the claim." When faced with these sudden “professional explanations”, consumers often find themselves in a dilemma where it is difficult to provide evidence and have no way to appeal.

There is also a type of warranty refusal due to omissions in the pre-sales and after-sales processes. An L brand car owner said that before transferring the vehicle from a company in his name to an individual, he repeatedly called customer service to confirm that the lifetime warranty rights were valid. After the transfer, he discovered that the original delivery specialist had forgotten to fill in the crucial "vehicle beneficiary" form, causing the lifetime warranty to disappear out of thin air. Another domestic B-brand car owner said that the 4S store where he bought the car closed down shortly after buying the car, but no other 4S store contacted him, and no one told him what to do next. It was not until he went to another 4S store for maintenance that he was told that because he did not renew the warranty at the 4S store, the lifetime warranty rights were gone.

Some car companies seem to use lifetime warranties as short-term marketing tools, playing a game of blurring time. A joint venture car company released a lifetime warranty policy in October 2025, promoting that the first car owner can receive it for free. However, some car owners said that after purchasing the car in February 2026, they were told that they could not enjoy this benefit because "the activity ended on December 31, 2025." The car owner checked all public information and found no expiration date or notice of the end of the event. This kind of operation of "sometimes selling, but not after paying the money" makes car owners feel deeply cheated.

Lifetime warranty reduced to marketing gimmick

Why has the lifetime warranty, a promise that should be the "ballast stone" for brand reputation, become a "stumbling block" on the road to consumer rights protection?

First of all, for many car companies, "lifetime warranty" is essentially a marketing strategy. In the early stages of vehicle sales, this commitment can greatly eliminate consumers' purchasing concerns and enhance brand premium and market competitiveness. However, as vehicles age, vehicle failure rates increase and maintenance costs accumulate. When "warranty" changed from "marketing cost" to "real liability", some car companies began to find ways to set up obstacles, trying to exclude most car owners from the warranty through strict additional conditions.

At present, whether it is the complete vehicle warranty or the three-electricity warranty launched by car companies, they have formulated elaborate restrictive clauses, keeping consumers on the verge of "default" forever. For example, some brands require maintenance intervals of "transmission oil must be changed within 2 years", "annually or 10,000 kilometers", or all recommended replacement parts must be replaced, etc. In reality, any tiny movement may become a switch that triggers "out of warranty".

Faced with endless "word games", consumers are usually stuck in the dilemma of providing evidence. Although the policy stipulates that "damage caused by failure to maintain is exempt from liability," the definition of "caused" is often left to the unilateral judgment of the 4S store. When consumers question whether the two are unrelated, they need to provide proof themselves. However, in the face of complex automotive technology, individual car owners can hardly afford the high appraisal costs.

Secondly, regulatory policies lack mandatory standards for the scope of “lifetime warranty”. The current law stipulates the basic rights and interests during the validity period of the three guarantees. However, the law does not provide a mandatory definition of the "lifetime warranty" launched by car companies, which parts are specifically included and what circumstances are exempt. This gives car companies a lot of room for "explanation".

With a high degree of freedom, car companies can even choose which models to provide lifetime warranties and which models not to provide them. Some car owners reported that 24 models released by a certain brand have a lifetime warranty for the entire vehicle or three electric vehicles. The extended range version and 26 pure electric versions released at the end of 2025 also enjoy a lifetime warranty. Only the 25 pure electric versions sandwiched in the middle have been "selectively forgotten." This kind of "new and old standards" approach does not directly violate the contract, but it greatly hurts brand loyalty and the emotions of old users.

Furthermore, current policies and regulations do not provide sufficient supervision and punishment for “formal clauses”. Although the Consumer Rights Protection Law and its Implementation Regulations clearly prohibit unfair standard clauses, in actual implementation, there are often more mediations on a case-by-case basis and fewer administrative penalties. The cost of breaking the law is far lower than the cost of fulfilling warranty commitments, leading some car companies to go to court with consumers rather than happily fulfill their commitments.

Competition in the current auto market is becoming increasingly fierce, but "lifetime warranty" should not be a piece of pie offered by auto companies to consumers, nor should it be just a marketing gimmick. Change requires the joint efforts of many parties. On the one hand, car companies need to show sincerity, launch high-quality products and fulfill their lifetime warranty promises. On the other hand, regulatory authorities should also issue detailed guidelines on the "lifetime warranty" promise as soon as possible. For consumers, when purchasing a car, in addition to paying attention to "whether there is a lifetime warranty", they should also pay attention to "under what circumstances is it not guaranteed" and fix the evidence in writing.

Click to enter the topic:

315 Consumer Rights Day: Focus on consumer rights protection on 3.15

CBA Regular Season: Xinjiang Vs. Jilin At Home, Game Process And Player Data Details

Live Broadcast March 13 News The CBA regular season continues. Xinjiang faces Jilin at home. Xinjiang beat Guangdong in the first game of the second stage. Currently, it ranks 14th in the league with 10 wins and 14 losses. Jilin ranks 15th with 9 wins and 15 losses.

At the beginning of this campaign, the two sides were a little slow to test each other. In the middle, Xinjiang took the lead in combining internal and external efforts. Moore teamed up with Wilson to respond promptly. At the end of the first quarter, Xinjiang led by 4 points. Returning to the second quarter, Xinjiang's offense suddenly stopped and only scored 13 points in a single quarter. Moore and Wilson continued to score points and led the team to come from behind. After halftime, Jilin overtook and established an 8-point advantage. After a short break, Xinjiang regained its offensive feeling and once again took the lead with a 9-0 wave. The two teams went back and forth to close the score. Jilin played steadily to hold on to the advantage. After the end of the three quarters, Jilin still led by 4 points. In the final decisive battle, Moore's handwriting was smooth and he scored three consecutive points. Xinjiang was unable to reverse the pursuit of points. In the end, Jilin defeated its opponent 89-82.

_Jilin defeated Xinjiang Moore with 34 points in the card position battle, Wilson 19+8+6, Nuttall 14 points_Jilin defeated Xinjiang Moore with 34 points in the card position battle, Wilson 19+8+6, Nuttall 14 points

Player data:

Jilin (10-15): Moore 34 points, 5 rebounds and 3 assists, Wilson 19 points, 8 rebounds and 6 assists, Jiang Weize 13 points, 3 rebounds and 4 assists, Luan Licheng 10 points, 2 rebounds and 1 assist, Jia Hao 7 points and 4 rebounds, Liu Yanyu 4 points, 1 rebound and 1 assist, Zeng Fanri 2 points, 3 rebounds and 1 assist

Xinjiang (10-15): Nuttall 14 points, 2 rebounds and 3 assists, Abdul Saramu 13 points and 3 rebounds, Lawson 12 points, 6 rebounds, 3 assists and 2 steals, plus 10 points, 1 rebound and 1 assist, Harris 10 points, 1 rebound, 1 assist and 3 steals, Yang Rui 10 points, 1 board and 2 steals, Yili Fulati 6 points, 6 rebounds and 3 assists, Feng Ao 4 points and 1 rebound, Li Yanzhe 3 points and 2 rebounds, Qu Xiaoyu 8 rebounds, Ge Haoran 3 assists

Click to enter the topic:

2025-2026 CBA League Season

Ubisoft And Netflix Create Assassin's Creed Live-action Drama, To Start Production In Italy, May Be Broadcast In 2027

According to VG Times, the "Assassin's Creed" live-action series jointly produced by Ubisoft and Netflix has officially started filming in Rome, Italy. The series will continue to revolve around the secret struggle between the classic Assassin's Creed organization and the Templars.

For old fans of the series, the Italian story background of this game may be exciting, but unlike the Italian assassin Ezio we are familiar with, the story of this game will be about 1,400 years earlier. It will tell the story of Rome during the reign of Nero, and introduce new original characters and plots.

According to current information, this drama is not expected to be broadcast until the second half of 2027 at the earliest. For Ubisoft, this adaptation is another major attempt after the 2016 "Fashion" version of the "Assassin's Creed" movie.

In terms of the starring cast, the male lead is played by Toby Wallace, who appeared in the third season of "Euphoria"; the female lead is played by Lola Petticrew, who received attention for her appearance in "Keep Silent".

The creative team of the show includes Roberto Patino, who has participated in the production of "Westworld", and David Wiener, who participated in the production of the second season of "Halo", will serve as the series coordinator. The director is Emmy Award winner Johan Renck.

It is also worth mentioning that Ubisoft has previously hinted that the "Assassin's Creed" live-action drama will have major announcements in the future, but it cannot reveal much information in the short term.

From the 2016 movie version to today's live-action drama, the film and television version of "Assassin's Creed" has always attracted players' attention. This time, the story is not only set in ancient Rome during the Nero period, but also uses completely original characters and plots. Do you think this adaptation will have more room for development, or will it make the series less familiar? Welcome to chat about your views in the comment area.

Market Conditions On March 12: The Rise And Fall Of Multiple Sectors And Details Of ETF Capital Flows

The market bottomed out yesterday and rebounded, with the three major indexes narrowing their losses in the afternoon. In terms of sectors, the concept of green power has exploded, the chemical sector continues to strengthen, and the coal sector is active. On the downside, the gas turbine concept continued to adjust, and the military industry sector weakened.

Wind data shows that in the non-monetary ETF market on March 12, E Fund’s new energy battery ETF fund share increased by 350 million shares, with a net inflow of 826 million yuan; China Securities SSE Science and Technology Innovation Board 50 ETF fund share increased by 405 million shares, with a net inflow of 592 million yuan; China Securities Power Grid Equipment Theme ETF Fund share increased by 230 million shares, with a net inflow of 479 million yuan.

At the same time, China Southern CSI 500 ETF fund shares decreased by 212 million shares, with a net outflow of 1.787 billion yuan; China AMC SSE 50 ETF fund shares decreased by 311 million shares, with a net outflow of 946 million yuan; Southern CSI 1000 ETF fund shares decreased by 244 million shares, with a net outflow of 812 million yuan.

As of March 12, the list of the top 20 ETFs with the largest net capital inflows this month is as follows:

Overall, Wind data shows that as of March 12, the market share of ETFs was 3.363799 billion units; the total size was 5.286327 billion yuan. In the past week, the industry with the largest increase in share was industrial, tracked by 1 fund. The theme with the largest increase in share is CSI Agriculture, tracked by 4 funds. The index subject with the largest increase in share is the theme of power grid equipment, tracked by 1 fund; the index subject with the highest return is Yisheng Nenghua A (+14.96%), tracked by 1 fund.

daily economic news

Xuanya International's Closing Information On March 12 And Summary Of The Day's Concerns

As of the close on March 12, 2026, Xuanya International (300612) closed at 15.96 yuan, down 1.97%, with a turnover rate of 3.93%, a trading volume of 70,700 hands, and a turnover of 114 million yuan.

Focus of the day

Transaction information summary

Fund flow

On March 12, the net outflow of main funds was 17.9518 million yuan; the net inflow of hot money was 4.1025 million yuan; the net inflow of retail funds was 13.8493 million yuan.

Summary of company announcements

Zhongde Securities Co., Ltd.’s report on the company’s continuous supervision and regular on-site inspection in 2025

Sino-German Securities conducted an on-site inspection of Xuanya International’s continuous supervision in 2025. The inspection period is 2025, and the on-site inspection time is from February 9 to March 4, 2026. The inspection content covers corporate governance, internal control, information disclosure, use of raised funds, performance, commitment fulfillment, etc. The inspection results showed that the corporate governance system is sound and effectively implemented, the three committees operate in a standardized manner, information disclosure is compliant, the use of raised funds complies with regulations, and there are reasonable explanations for performance fluctuations. The company's net profit in 2025 is expected to be a loss of 85 million yuan to 59 million yuan, an increase from the previous year's loss. The main reasons include an increase in share-based payment expenses and a full impairment provision for Tianjin Xingyan Yunhui's goodwill. The company has completed the reform of the board of supervisors, the audit committee has taken over the powers of the board of supervisors, and changed the use of some raised funds.

The above content is compiled by Securities Star based on public information and generated by an AI algorithm (Network Information No. 310104345710301240019) and does not constitute investment advice.

Summary Of Closing Information And Company Announcements Of *ST Jingfeng (000908) On March 12, 2026

As of the close on March 12, 2026, *ST Jingfeng (000908) closed at 4.81 yuan, an increase of 5.02%, with a turnover rate of 0.0%, a trading volume of 295.0 lots, and a transaction volume of 142,100 yuan.

Focus of the day

Transaction information summary fund flow

On March 12, the net inflow of main funds was 134,400 yuan; the net outflow of hot money was 48,100 yuan; the net outflow of retail funds was 86,300 yuan.

Summary of company announcements Morgan Stanley Securities (China) Co., Ltd.’s interim report on the trusteeship management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.’s public issuance of corporate bonds (first phase) to qualified investors in 2016

Hunan Jingfeng Pharmaceutical Co., Ltd. implemented the conversion of capital reserve funds into share capital. Based on the existing total share capital of 879,774,351 shares, 10 shares were converted for every 10 shares, resulting in a total of 879,774,351 shares. After the conversion, the total share capital increased to 1,759,548,702 shares. The registration date for this equity transfer is March 10, 2026, and the listing date for the equity transfer is March 11, 2026. The company's stock (securities abbreviation: *ST Jingfeng, stock code: 000908) will be suspended for one day from the market opening on March 10, 2026, and will resume trading from the market opening on March 11, 2026.

Morgan Stanley Securities (China) Co., Ltd.’s Interim Report on the Trusteeship of Hunan Jingfeng Pharmaceutical Co., Ltd.’s Public Issuance of Corporate Bonds to Qualified Investors in 2016 (First Phase)

Due to the implementation of the reorganization plan, Hunan Jingfeng Pharmaceutical Co., Ltd. converted its capital reserve to increase its share capital by converting 879,774,351 shares at a rate of 10 shares for every 10 shares. After the conversion, the total share capital increased to 1,759,548,702 shares. The reorganization investors paid RMB 2,060,857,594.18 in cash for the transferred shares, with an average price of RMB 2.34 per share. The equity registration date is March 10, 2026. The company's stock was suspended from trading on that day. The closing price was 6.37 yuan/share on the previous trading day, which was higher than the average transfer price. Therefore, the opening reference price on the next trading day was adjusted to 4.36 yuan/share. The company has entered the implementation stage of the reorganization plan. If the implementation fails, it will face the risk of being declared bankrupt and the stock being delisted.

The above content is compiled by Securities Star based on public information and generated by an AI algorithm (Network Information No. 310104345710301240019) and does not constitute investment advice.

Xi Mengyao Posted A Family Photo On Her 37th Birthday, A Family Of Four Sharing A Cozy Frame, And He Youjun Dotes On His Wife

On March 9, Xi Mengyao posted a family photo on social platforms to celebrate her 37th birthday. The picture of a family of four in the same frame is warm and loving.

In the photo, Xi Mengyao has long hair and appears in a white sweater. She looks beautiful and elegant in a simple dress. Husband He Youjun looked handsome in a black coat. A pair of children cuddled up next to their mother. The son, He Guangshen, was dressed cutely in a gray sweater. Daughter Romee is very cute in a white sweater. A family of four are pictured together, looking happy.

Xi Mengyao posted a photo of her husband He Youjun. The two of them were smiling and seemed to be in perfect harmony with each other, showing their love and sweetness. By the way, Xi Mengyao really doesn't look 37 years old in this state, and she looks more and more beautiful. And He Youjun really dotes on his wife. Not only did he prepare three different birthday cakes, but there were also many beautiful flowers. It was really romantic.

Xi Mengyao also posted a selfie with her daughter. The 4-year-old Romee held her face in her hands and looked cute at the camera. Although her face was covered with stickers, it can be seen that the little princess is really cute. Xi Mengyao leaned close to her daughter, with a sweet smile on her face. Mother and daughter are so loving when they are in the same frame. They are so happy.

Xi Mengyao rarely shares updates about her children, and even when she takes photos, she hides her children's faces. However, it can be seen that both children have inherited their mother's superior height. The 6-year-old son He Guangshen is tall and thin, and he is expected to be a tall and handsome boy in the future.

Daughter Romee is very cute. She also inherited her mother's tall stature. Her long legs are very eye-catching. She will definitely have a supermodel figure in the future.

Xi Mengyao and He Youjun got married in 2019, and gave birth to their son He Guangshen in the same year. Their second daughter, Romee, was born in 2021. They have been together for three years and the word "good" has made them a happy and enviable family of four.

Sign In

Forgot Password

Sign Up